|Feasibility of screening for Lynch syndrome among patients with colorectal cancer|
H Hampel, WL Frankel, E Martin, M Arnold, K Khanduja, P Kuebler, ...
Journal of Clinical Oncology 26 (35), 5783, 2008
|Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients|
H Hampel, W Frankel, J Panescu, J Lockman, K Sotamaa, D Fix, ...
Cancer research 66 (15), 7810-7817, 2006
|The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations|
L Senter, M Clendenning, K Sotamaa, H Hampel, J Green, JD Potter, ...
Gastroenterology 135 (2), 419-428. e1, 2008
|Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database|
BA Thompson, AB Spurdle, JP Plazzer, MS Greenblatt, K Akagi, ...
Nature genetics 46 (2), 107-115, 2014
|Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study|
AK Win, JP Young, NM Lindor, KM Tucker, DJ Ahnen, GP Young, ...
Journal of clinical oncology 30 (9), 958, 2012
|Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics|
K Lagerstedt Robinson, T Liu, J Vandrovcova, B Halvarsson, ...
Journal of the national cancer institute 99 (4), 291-299, 2007
|Cancer Risks for MLH1 and MSH2 Mutation Carriers|
JG Dowty, AK Win, DD Buchanan, NM Lindor, FA Macrae, M Clendenning, ...
Human mutation 34 (3), 490-497, 2013
|Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome|
AK Win, NM Lindor, JP Young, FA Macrae, GP Young, E Williamson, ...
Journal of the National Cancer Institute 104 (18), 1363-1372, 2012
|Prevalence and penetrance of major genes and polygenes for colorectal cancer|
AK Win, MA Jenkins, JG Dowty, AC Antoniou, A Lee, GG Giles, ...
Cancer Epidemiology and Prevention Biomarkers 26 (3), 404-412, 2017
|Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for …|
DD Buchanan, YY Tan, MD Walsh, M Clendenning, AM Metcalf, ...
Journal of Clinical Oncology 32 (2), 90, 2014
|Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype|
MD Walsh, M Clendenning, E Williamson, SA Pearson, RJ Walters, ...
Modern Pathology 26 (12), 1642-1656, 2013
|Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer|
AK Win, JG Dowty, SP Cleary, H Kim, DD Buchanan, JP Young, ...
Gastroenterology 146 (5), 1208-1211. e5, 2014
|Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features|
C Rosty, JP Young, MD Walsh, M Clendenning, RJ Walters, S Pearson, ...
Modern Pathology 26 (6), 825-834, 2013
|PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival|
C Rosty, JP Young, MD Walsh, M Clendenning, K Sanderson, RJ Walters, ...
PloS one 8 (6), e65479, 2013
|BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome|
CW Toon, MJ Walsh, A Chou, D Capper, A Clarkson, L Sioson, S Clarke, ...
The American journal of surgical pathology 37 (10), 1592, 2013
|Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study|
R Dienstmann, MJ Mason, FA Sinicrope, AI Phipps, S Tejpar, ...
Annals of Oncology 28 (5), 1023-1031, 2017
|Long‐range PCR facilitates the identification of PMS2‐specific mutations|
M Clendenning, H Hampel, J LaJeunesse, A Lindblom, J Lockman, ...
Human mutation 27 (5), 490-495, 2006
|Cancer risks for PMS2-associated Lynch syndrome|
W Sanne, HM van der Klift, CMJ Tops, S Aretz, I Bernstein, DD Buchanan, ...
Journal of Clinical Oncology 36 (29), 2961, 2018
|Cancer risks for relatives of patients with serrated polyposis|
AK Win, RJ Walters, DD Buchanan, MA Jenkins, K Sweet, WL Frankel, ...
The American journal of gastroenterology 107 (5), 770, 2012
|Aspirin, ibuprofen, and the risk for colorectal cancer in Lynch Syndrome|
D Ait Ouakrim, SG Dashti, R Chau, DD Buchanan, M Clendenning, ...
JNCI: Journal of the National Cancer Institute 107 (9), 2015